KP
CELG

Keel Point’s Celgene Corp CELG Stock Holding History

Keel Point’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,277
Closed -$292K – 185
2018
Q1 		$292K Hold
3,277
– – 0.04% 127
2017
Q4 		$342K Buy
3,277
+7
+0.2% +$790 0.05% 127
2017
Q3 		$477K Buy
3,270
+26
+0.8% +$3.54K 0.07% 101
2017
Q2 		$421K Buy
3,244
+141
+5% +$17.3K 0.08% 101
2017
Q1 		$386K Buy
3,103
+28
+0.9% +$3.35K 0.08% 106
2016
Q4 		$356K Buy
+3,075
New +$342K 0.08% 106

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Keel Point's CELG Position: Q2 2018 in Review

Keel Point sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 3,277 shares — an estimated $292K sold.

Keel Point first reported a position in CELG in Q4 2016 and held it in 6 quarters. The position peaked at $477K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Keel Point reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Keel Point sold 3,277 Celgene Corp shares in Q2 2018, an estimated $292K.
  • Keel Point first reported a position in Celgene Corp in Q4 2016 and held it in 6 quarters.
  • Keel Point's Celgene Corp position peaked at $477K in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Keel Point's 13F filing for Q2 2018, filed 13 Aug 2018.